Electrophysiological correlates of cardiac sarcoidosis: An appraisal of current evidence

Mrinal Yadava, Rupa Bala

Research output: Contribution to journalArticle

Abstract

Cardiac sarcoidosis is an underdiagnosed condition that may be present in as many as 25% of patients with systemic sarcoidosis. It is associated with significant morbidity and mortality in affected individuals. The presentation of cardiac involvement in sarcoidosis includes sudden death in the absence of preceding symptoms, conduction disturbances, ventricular arrhythmias, and heart failure. A scarcity of randomized data and a lack of prospective trials underlies the contention between experts on the most appropriate strategies for diagnosis and therapy. This review focuses on the electrophysiological sequelae of the disease, with an emphasis on current diagnostic guidelines, multimodality imaging for early detection, and the role of various therapeutic interventions. Multicentre collaboration is necessary to address the numerous unanswered questions pertaining to management of this disease.

Original languageEnglish (US)
Pages (from-to)392-401
Number of pages10
JournalTurk Kardiyoloji Dernegi Arsivi
Volume43
Issue number4
DOIs
StatePublished - Jun 1 2015

Fingerprint

Sarcoidosis
Disease Management
Sudden Death
Cardiac Arrhythmias
Heart Failure
Guidelines
Morbidity
Mortality
Therapeutics

Keywords

  • Cardiac sarcoidosis
  • Implantable cardioverter-defibrillator
  • Sudden death
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Electrophysiological correlates of cardiac sarcoidosis : An appraisal of current evidence. / Yadava, Mrinal; Bala, Rupa.

In: Turk Kardiyoloji Dernegi Arsivi, Vol. 43, No. 4, 01.06.2015, p. 392-401.

Research output: Contribution to journalArticle

@article{bdfd07b04a3645e490413f8954bbc1cd,
title = "Electrophysiological correlates of cardiac sarcoidosis: An appraisal of current evidence",
abstract = "Cardiac sarcoidosis is an underdiagnosed condition that may be present in as many as 25{\%} of patients with systemic sarcoidosis. It is associated with significant morbidity and mortality in affected individuals. The presentation of cardiac involvement in sarcoidosis includes sudden death in the absence of preceding symptoms, conduction disturbances, ventricular arrhythmias, and heart failure. A scarcity of randomized data and a lack of prospective trials underlies the contention between experts on the most appropriate strategies for diagnosis and therapy. This review focuses on the electrophysiological sequelae of the disease, with an emphasis on current diagnostic guidelines, multimodality imaging for early detection, and the role of various therapeutic interventions. Multicentre collaboration is necessary to address the numerous unanswered questions pertaining to management of this disease.",
keywords = "Cardiac sarcoidosis, Implantable cardioverter-defibrillator, Sudden death, Ventricular tachycardia",
author = "Mrinal Yadava and Rupa Bala",
year = "2015",
month = "6",
day = "1",
doi = "10.5543/tkda.2015.53333",
language = "English (US)",
volume = "43",
pages = "392--401",
journal = "Turk Kardiyoloji Dernegi Arsivi",
issn = "1016-5169",
publisher = "Turkish Anaesthesiology and Intensive Care Society",
number = "4",

}

TY - JOUR

T1 - Electrophysiological correlates of cardiac sarcoidosis

T2 - An appraisal of current evidence

AU - Yadava, Mrinal

AU - Bala, Rupa

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Cardiac sarcoidosis is an underdiagnosed condition that may be present in as many as 25% of patients with systemic sarcoidosis. It is associated with significant morbidity and mortality in affected individuals. The presentation of cardiac involvement in sarcoidosis includes sudden death in the absence of preceding symptoms, conduction disturbances, ventricular arrhythmias, and heart failure. A scarcity of randomized data and a lack of prospective trials underlies the contention between experts on the most appropriate strategies for diagnosis and therapy. This review focuses on the electrophysiological sequelae of the disease, with an emphasis on current diagnostic guidelines, multimodality imaging for early detection, and the role of various therapeutic interventions. Multicentre collaboration is necessary to address the numerous unanswered questions pertaining to management of this disease.

AB - Cardiac sarcoidosis is an underdiagnosed condition that may be present in as many as 25% of patients with systemic sarcoidosis. It is associated with significant morbidity and mortality in affected individuals. The presentation of cardiac involvement in sarcoidosis includes sudden death in the absence of preceding symptoms, conduction disturbances, ventricular arrhythmias, and heart failure. A scarcity of randomized data and a lack of prospective trials underlies the contention between experts on the most appropriate strategies for diagnosis and therapy. This review focuses on the electrophysiological sequelae of the disease, with an emphasis on current diagnostic guidelines, multimodality imaging for early detection, and the role of various therapeutic interventions. Multicentre collaboration is necessary to address the numerous unanswered questions pertaining to management of this disease.

KW - Cardiac sarcoidosis

KW - Implantable cardioverter-defibrillator

KW - Sudden death

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=84941554138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941554138&partnerID=8YFLogxK

U2 - 10.5543/tkda.2015.53333

DO - 10.5543/tkda.2015.53333

M3 - Article

C2 - 26142797

AN - SCOPUS:84941554138

VL - 43

SP - 392

EP - 401

JO - Turk Kardiyoloji Dernegi Arsivi

JF - Turk Kardiyoloji Dernegi Arsivi

SN - 1016-5169

IS - 4

ER -